AbbVie (ABBV) to acquire Arizona manufacturing facility, strengthening their manufacturing presence in the US

• The acquisition will see AbbVie hire approximately 200 employees at the site, investing more than USD 175mln.

AbbVie's acquisition of a manufacturing facility in Arizona is a strategic move to bolster its domestic production capabilities, involving a significant investment of over $175 million and the addition of around 200 jobs. This move not only enhances their operational capacity but also reflects a commitment to strengthening their supply chain in the U.S. market, which could improve production efficiency and potentially support revenue growth in the long run.